Programme 2019

Download Programme
REGISTER NOW

Wednesday, 4 December

   to download session to your calendar click on this icon

* Competing for the MAC Award

13.00-14.05

VEN 1: Case discussions and short communications on Venous Diseases and Vascular Malformations | Lecture Hall B

Chair: Sylvia Haas, Athanasios Giannoukas, Nicholas Leeper
Dmitry DombrovskyStem cells of cord blood in the complex treatment of chronic venous ulcer that do not heal
Andrij NykonenkoSurgery for Nutcracker Syndrome – should we wait until hematuria occurs?
Ihor KobzaAnalysis of the remote results of “the Nutcracker Syndrome” surgical treatment
Mohamed NagibPercutaneous insertion of peripheral vein port catheter for chemotherapy in cancer patients
Iris BaumgartnerEndovascular port-a-cath rescue in acute thrombotic superior vena cava syndrome
Yaroslav KhrebtiyAspiration thrombectomy in the treatment of pulmonary embolism
Ahmed Allam18 month outcomes of patch angioplasty and balloon angioplasty after thrombectomy of AV hemodialysis grafts
Ahmed AllamSafety and efficacy of infraclavicular arterioarterial prosthetic loop graft for hemodialysis access: a review of 45 patients
Adel KamhawyFoam sclerotherapy guided by non-touch laser for management of bleeding scrotal angiokeratoma
Sohiel NagibSclerotherapy of lymphangioma in children: report of 3 cases
Iris BaumgartnerKeynote Lecture: What a vascular specialist needs to know about the management of vascular malformations

14.30-15.40

VEN 2: Primary varicosis (from stripping to glue) and superficial venous thrombosis | Lecture Hall B

Chair: Martin Storck, Alun Davies
Andrew BradburyUltrasound-guided foam sclerotherapy vs. endothermal ablation for the treatment of GSV varicosis – a review of RCTs
Kurşat BozkurtThe 2019 ECP Guideline recommends laser or radiofrequency over surgery or foam sclerotherapy for greater GSV reflux
Athanasios GiannoukasKeynote lecture: Complications of foam sclerotherapy and lessons learned from the treatment of varicose veins with ablation techniques
Mojahid Najem*Single centre experience with cyanoacrylate glue for the first 100 truncal veins using the VenaSeal™ Closure System
Douglas Wooster*Do ultrasound characteristics of superficial venous thrombosis predict progression?
Nicholas LeeperKeynote Lecture: Clinical and genetic determinants of varicose veins

15.45-16.35

VEN 3: How to prevent and how to treat severe chronic insufficiency and venous ulcers | Lecture Hall B

Chair: Houman Jalaie, Iris Baumgartner
Alun DaviesKeynote Lecture: Early vs. deferred endovenous ablation of superficial venous reflux in patients with venous ulceration: the EVRA RCT
Efthymios AvgerinosVenous ulceration – ablate the superficial reflux early, but don't neglect deep reflux or obstruction 
Andrew BradburyObesity and lower limb venous disease – the epidemic of phlebesity
Martin StorckCompetence levels in wound care – how networks should be organized – a German consensus statement

17.00-18.30

VEN 4: Acute deep venous thrombosis of the lower extremity – advances in endovascular therapy | Lecture Hall B

Chair: Kurşat Bozkurt, Andrew Bradbury
Sylvia HaasLatest real-world evidence of venous thromboembolism (VTE) treatment from the GARFIELD-VTE Registry
Efthymios AvgerinosCatheter interventions for acute DVT – who, when, and how
Iris BaumgartnerEndovascular venous therapy after the ATTRACT trial
Houman JalaiePercutaneous mechanical thrombectomy – is it the future of lower extremity DVT therapy?
Gabriel SzendroPregnancy after thrombolysis and stenting for ilio-femoral DVT – outcomes and complications
Rupert BauersachsKeynote Lecture: The management of venous thromboembolism in patients with cancer

Thursday, 5 December

* Competing for the MAC Award

08.30-09.35

AOR 1: The evolution of endovascular aortic arch repair | Lecture Hall B

Chair: Sabine Wipper, Jean-Pierre Becquemin
Vicente RiambauArch endovascular repair – multiple solutions from a single brand endograft 
Ludovic CanaudPhysician-made endografts for aortic arch aneurysms – indication, technique, and outcomes
Martin CzernyTotal endovascular aortic arch repair
Hubert SchelzigNexus Aortic Arch single branch stentgraft system – mid-term results
Nicola MangialardiA new semi custom-made fenestrated TEVAR for non-A-non-B aortic dissections and bovine arch lesions
Matthias TrennerAortic arch pathologies with aberrant right subclavian artery
Gustavo OderichPrevention and management of endoleaks after endovascular aortic arch repair

09.35-11.10

AOR 2: Thoraco-abdominal aortic aneurysms (TAAA) and type B aortic dissections | Lecture Hall B

Chair: Piotr Kasprzak, Natzi Sakalihasan
Franco GregoEndovascular and surgical treatment of acute type B dissection:
single-centre experience
Jean-Pierre BecqueminUncomplicated aortic type B dissection – when to intervene? 
Rachel CloughEvidence of endovascular treatment of asymptomatic acute type B aortic dissections – is TEVAR really good?
Bijan ModaraiComplex endografting for post dissection thoracoabdominal aortic aneurysms
Martin CzernyTreatment of multisegmental thoracoabdominal pathology by a 3 step approach
Sabine Wipper*The new Thoracoflo® graft for thoracoabdominal hybrid-repair – from bench to bedside
Athanasios KatsargyrisBridging stent grafts in fenestrated and branched EVAR – long term durability and need for improvements?
Nicola MangialardiThe „bare branch“ for safe spinal cord ischaemia prevention after total endovascular repair of TAAA
Martin AustermannResults of a bench test of different covered stents as bridging stentgrafts in a flat FEVAR model
Gustavo OderichKeynote Lecture: The evolution of branched and fenestrated endografts for TAAA – lessons learned

11.30-13.00

AOR 3: AAA – Endoleak prevention and management | Lecture Hall B

Chair: Bijan Modarai, Anders Wanhainen
Jean-Paul de VriesImplications of aortic straightening after endovascular aortic aneurysm repair
Colin BicknellMigration patterns of modern aortic stent grafts
Vicente RiambauAortic aneurysm sac reduction – the only real indicator for success after EVAR
Alan LumsdenKeynote Lecture: Novel approaches to endoleaks after EVAR
Mauro GargiuloSelective intra-procedural AAA sac embolization during EVAR reduces the rates of type II endoleak
Martin StorckHow safe is infrarenal proximal polymer neck sealing during EVAR and does it prevent type I endoleaks?
Dainis KrievinsDo kissing endografts work in (non-)ruptured AAAs?
Jean-Pierre BecqueminKeynote Lecture: The mystery of type II endoleaks – will they ever be prevented?

13.50-15.15

AOR 4: NICE guidelines from the UK and miscellaneous issues on AAA | Lecture Hall B

Chair: Gustavo Oderich, Hubert Schelzig, Tina Cohnert
The controversy about the recommendations of the UK National Institute for Health and Care Excellence (NICE)
Andrew BradburyKeynote Lecture: Rationale and background of the AAA guidelines of the NICE institute (UK)
Vicente RiambauEVAR after NICE guidelines: what should we do and what should we not do?
Christos LiapisAre the NICE guidelines for the intact AAA going to affect the outcome of patients with ruptured AAAs?
Round table discussion moderated by Hubert Schelzig
Miscellaneous issues on AAA
Qasam Ghulam*Clinical validation of three-dimensional ultrasound for abdominal aortic aneurysms
Andrew ChoongCan we forecast aortic aneurysm rupture? The relationship with the weather
Sebastian DebusIs there a weekend effect in short and long term outcomes after ruptured AAA?
Thomas Schmitz-RixenRisk prediction model of in-hospital mortality following elective AAA repair – a dual score assessment
Jes LindholtUnchanged AAA growth rates, declined mortality, and increased later repair rates – should we lower the threshold for preventive AAA repair?

16.45-18.15

AOR 5: Case discussions and short communications on aortic disease | Lecture Hall C

Chair: Christoph Knappich, Christos Liapis, Gert J. de Borst
Matthias TrennerPercutaneous EVAR/TEVAR is a real progress – however, there are some limitations
Giuseppe BaldinoClinical and economic impact of “Pevar-first” approach in daily practice – a single-center experience
Felix Menges*All AAA are not the same – clinical and morphological data from the histAAA consortium on 550 AAAs
Vedran PazurAcute abdominal pain with renal ischaemia 18 months after EVAR
Konstantinos SpanosLessons learned from a pilot AAA screening program in central Greece
Georgios SachsamanisMid-term results following open surgical and endovascular management of uretero-arterial fistula
Olga BuchnievaPossibility of acute ascending aortic dissection surgery with moderate hypothermic circulatory arrest
Inga Dakovic BacaljaJuxtarenal abdominal aorta intimal dissection in blunt trauma
Nikolaos FlorosFirst-in-man clinical application of the TrackCath system in EVAR of AAA – a prospective multi-centre clinical trial
Ahmed SayedManagement of distal entry tears at the visceral segment in aortic dissections by bare metal stent
Richte SchuurmannValidation of accurate assessment of proximal and distal endograft apposition after TEVAR
Francesco SturlaHelical blood flow pattern in the bovine aortic arch variant as a potential risk factor for aortic dissection
Nuno Henriques CoelhoConcomitant aneurysmatic/occlusive aortoiliac disease – multiple-step hybrid procedure as a solution to a nightmare
Vakhtang KipianiLong-term complication after open repair for aortoiliac occlusive disease treated successfully with hybrid technique
Haifeng WangComputer simulation of flow in an elastic aneurysm – elasticity competes with size effects

13.05-13.50

The Venous Challenge – successful strategies to treat venous
lesions (Industry-sponsored) | Lecture Hall B

Chair: Tobias Steinke
Tobias SteinkeThe endovascular option for AV-fistula creation
Vladimir MatoussevitchHow to treat the AV-fistula stenosis best
Houman JalaieThe right way to treat chronic venous lesions – tips and tricks in diagnostic, indication, and treatment

* Competing for the MAC Award

08.30-10.00

CAD 1: Case discussions and short communications on carotid artery disease | Lecture Hall C

Chair: Pavlos Tsantilas, Alison Halliday, Colin Bicknell
Farahnaz Waissi Tenascin-C is highly expressed in unstable carotid endarterectomy plaques
Wojciech ZelawskiResults of endovascular interventions on asymptomatic carotid sub-occlusion in one year observations
William YoonManaging carotid artery dissection during TCAR using transfemoral approach
Klaus MathiasA challenging rescue maneuver after inadverted stenting of the external carotid artery
Marjolijn RotsIntraoperative hypotension is a risk factor for silent brain ischaemia in hypertensive patients undergoing CEA
Constance van Laarhoven3T gadolinium-enhanced MR imaging of extracranial carotid artery aneurysms
Ivan PertsovSimultaneous CEA and coronary bypass grafting
Gabriel SzendroEndovascular treatment of tracheo-innominate fistula – how to treat and how to do it successfully
Michiel PoorthuisDetection of asymptomatic carotid artery stenosis in 0.6M screening participants
Kosmas ParaskevasScreen for abdominal aortic aneurysms is considered to be rational, screening for carotid stenosis not. WHY?
Michiel PoorthuisContemporary stroke risks of carotid stenosis patients: design and characteristics of a prospective cohort study

10.30-12.00

CAD 2: Precision medicine for atherosclerosis and carotid artery disease | Lecture Hall C

Chair: Lars Maegdefessel, Julian Scott
Nicholas LeeperTargeting efferocytosis in atherosclerosis
Ulf HedinMultilevel biological and morphological analyses of carotid plaque instability
Konstantin StarkInterplay of cancer and atherothrombotic events
Philipp von HundelshausenTargeting inflammation in atherosclerosis: insights from clinical studies and basic research
Nathalie Timmerman*Protein levels in extracellular vesicles predict high-risk patients for secondary cardiovascular events: a pilot study
Farahnaz Waissi*Elevated Lipoprotein(a) levels increase risk of secondary major cardiovascular events in patients undergoing CEA
Jessica Pauli*Time-dependent changes in atherosclerotic lesions after a neurological index event

* Competing for the MAC Award

12.00-13.00

PAD 1: Update on lipid-lowering therapy in carotid and peripheral atherosclerosis | Lecture Hall C

Chair: Thomas Stadlbauer
Christos LiapisStatins’ withdrawal induces atherosclerotic plaque destabilization
Klaus ParhoferPlaque regression with a PCSK9 inhibitor as measured by intravascular ultrasound – does it work?
Iris BaumgartnerLipid lowering in PAD – how to achieve the targets
Maarit VenermoKeynote lecture: What ABI and TBI tell us about the outcomes of PAD and how clopidogrel and statins influence that

14.00-15.10

PAD 2: Case discussions and short communications on peripheral artery disease (PAD) | Lecture Hall C

Chair: Maarit Venermo, Mauro Gargiulo, Athanasios Katsargyris
Barend MeesThe CERAB technique – evidence and indications
Nuno Henriques CoelhoRate condition, unusual anatomy, elegant solution – an uncommon manifestation of Kawasaki disease
Sohail AhmedPellet embolus in ulnar artery – a rare vascular injury
Chaled Hussein Spinal cord stimulation – could it help in otherwise untreatable patients?
Sohiel NagibRetrograde popliteal approach with total SFA occlusion for revascularization of critical limb ischaemia
Ahmed AllamA prospective RCT of drug-coated balloon vs. POBA for femoropopliteal artery disease in diabetic patients: 12-month results
Arnaud KerzmannFemoropopliteal angioplasty with paclitaxel-coated balloon – 3 Belgian centres experience
Douglas WoosterVascular referral patterns and expectations: are they appropriate?
Ahmed AllamPercutaneous revascularization AQ4 as a feasible option for complex aortoiliac occlusive disease with fair 1-year outcome
Ivan BarnaAneurysms of the subclavian artery and its complications in TOS – clinical and pathogenetic features and choice of treatment
Tobias KopparaOptical Coherence Tomography (OCT) assessment of femoral lesions in PAD
Sanaz BadpaHollow fiber Polylactid Co-Glycolic Acid (PLGA) – collagen coated by Chitosan as a candidate for small diameter vascular graft

15.30-16.40

PAD 3: Recent developments in popliteal aneurysms and acute limb ischaemia | Lecture Hall B

Chair: Ludovic Canaud, Christoph Neumayer
Popliteal artery aneurysm (PAA)
Igor KončarOpen repair of popliteal aneurysms
Constance van Laarhoven*Co-prevalence of aneurysms in the vasculature, a systemic review and meta-analysis
Martin BjörckOpen or endovascular surgery for PAA – lessons learned from a large matched case-control study
Acute limb ischaemia
Gianmarco de DonatoAcute lower-limb malperfusion treated by endovascular thrombectomy – the INDIAN registry
Iris BaumgartnerAcute ischaemia management – the angiologists’s view
Gabriel SzendroAcute aortic occlusions: when endo and when open?
Martin BjörckKeynote Lecture: The ESVS guidelines on acute limb ischaemia – what is new?

16.45-18.15

PAD 4: Critical limb-threatening ischaemia (CLTI) and angiosome directed revascularization | Lecture Hall B

Chair: Johannes Gahlen, Mihai Ionac
Adel Kamhawy*Surgical management of pediatric arterial trauma of the extremities – report on 100 cases
Achim NeufangExternal polytetrafluoroethylene reinforcement of varicose autologous vein grafts produces durable bypass function
Jean-Paul de VriesAdded value of non-invasive tissue perfusion imaging during endovascular interventions for CLI patients
Jes LindholtPoor vascular efforts in preventing amputations in Denmark
Andrew BradburyLate outcomes and secondary analyses from BASIL-1 and perspectives of BASIL-2 and BASIL-3
Mohamed Nagib*Indirect (non angiosome) arterialization with foot arch revascularization in wound healing and foot salvage in CLI patients
Maarit VenermoDistal bypass improves flow in all angiosomes, however, endovascular treatment improves only the targeted angiosome
Mauro GargiuloImpact of angiosome- and non-angiosome-targeted peroneal bypass on limb salvage and healing in patients with CLTI
Andrew BradburyKeynote Lecture: Key recommendations from the Global Vascular Guideline on GVG on critical limb-threatening ischaemia

15.30-16.40

Special Session 1: The future of Vascular Surgery 1 – training, stress management,
and the role of physician assistants | Lecture Hall C

Chair: Rebecka Hultgren, Sebastian Debus
Maarit VenermoSimulation training streamlines the real-life performance in endovascular repair of ruptured AAA
Alan LumsdenOpen aortic training – how we do it
Jonas Peter EibergTraining on open aortic surgery in the endovascular era
Julian ScottStrength and flexibility assessment on surgeons before and after surgery, implications for rest and recovery
Colin BicknellMultidisciplinary team training is effective in reducing error in theatre – it should be mandatory in vascular units
Pavlos TsantilasThe risk of burnout – the perspective of a vascular surgical clinician scientist
Efthymios AvgerinosFrom admission to discharge – do physician assistants reduce the workload of vascular surgical trainees in the US?

Friday, 6 December

* Competing for the MAC Award

08.30-10.00

CAD 3: Carotid body tumors and miscellaneous issues | Lecture Hall C

Chair: Michael Kallmayer, Rachel Clough
Ross NaylorClinical presentation and operative complications in patients with carotid body tumors
Martin BjörckAdjunctive measures in difficult carotid body tumors
Tina Cohnert All carotid paraganglioma should be screened for gene mutations – implications for therapy and follow-up
Sofiane DridiUltrasound guided loco-regional anesthesia works perfect for CEA – experiences from >1,000 patients
Christoph KnappichIntraoperative Duplex Ultrasound detects more defects after CEA compared to angiography – final results of CIDAC
Angelos KarlasAdvances in optical and optoacoustic vascular imaging of the carotid bifurcation
Henrik SillesenWill the use of ultrasound contrast improve the value of carotid plaque morphology?
Leonie Fassaert*ClearSight for postoperative arterial blood pressure monitoring after carotid endarterectomy: a validation study

10.30-12.10

CAD 4: Asymptomatic carotid disease – multimodal approach | Lecture Hall B

Chair: Kornelia Kreiser, Dainis Krievins
Kosmas ParaskevasBest medical treatment alone may not be adequate for all patients with asymptomatic carotid stenosis
Ross NaylorStroke associated with restenosis after carotid interventions
Klaus MathiasCAS for post CEA restenosis – indications, technique, and outcomes
Gert de BorstNear occlusion of the internal carotid artery – meta-analysis of treatment outcomes
Laura CapocciaPeri-procedural brain lesions and cognitive alterations in CAS (3PCAS) – a RCT comparing CGuard™ stent vs. Wallstent™
Alison HallidayDoes CEA prevent dementia?
Michiel Poorthuis*Timing of procedural death and stroke after CEA for asymptomatic stenosis – analysis of VACS, ACAS, ACST-1, and GALA
Peter RothwellKeynote Lecture: Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose

13.30-15.05

CAD 5: NEWS from RCTs and high-quality registries on carotid stenosis | Lecture Hall B

Chair: Jean-Paul de Vries, Ulf Hedin
Mahmoud MalasUpdate of CREST-2
Gert de BorstUpdate of ECST-2
Alison HallidayACST-2 trial recruitment – our patients and their follow up
Mahmoud MalasCarotid endarterectomy, transfemoral CAS and transcarotid CAS – data from the SVS Vascular Quality Initiative (VQI)
Peter Rothwell Stenting for symptomatic vertebral artery stenosis: a preplanned pooled individual patient data analysis.
Richard BulbuliaRationale and design of the Vertebral Artery Ischaemia Stenting Trial-2 (VIST-2)
Michael KallmayerThe external validity of carotid RCTs – is the current evidence really transferrable to the „real world“?
Andreas KühnlKeynote Lecture: What did we learn from the German Carotid Registry

15.30-17.00

CAD 6: Personalized management of carotid-related cerebral ischaemia | Lecture Hall B

Chair: Claus Zimmer, Gabriel Szendro
Peter RothwellKeynote Lecture: Is the epidemiology of carotid-related cerebral ischaemia really changing?
Kornelia KreiserMechanical thrombectomy of intracranial occlusions and CAS should always be performed simultaneously – PRO
Laura CapocciaMechanical thrombectomy of intracranial occlusions and CAS should always be performed simultaneously – CONTRA
Klaus MathiasEndovascular thrombectomy in acute carotid occlusion is superior to surgical thrombectomy!
Pavlos TsantilasUrgent CEA (within 48 hours) is usually safe after transient carotid-related symptoms – right or wrong?
Holger PoppertIn some patients it remains to be wise to perform CEA or CAS not too early – which stroke patients are that?
Gert de BorstAcute clinical response to periprocedural stroke in carotid revascularization: a Delphi consensus analysis

12.10-13.00

Overcoming challenges in the endovascular treatment of the aorta and the peripheral arteries (Industry-sponsored) | Lecture Hall B

Chair: Alexander Hyhlik-Dürr
Kyriakos OikonomouPrecision and Accuracy within the Landing Zones: practical experience using GORE® TAG® Conformable Stent Graft with ACTIVE CONTROL System
Alexander Hyhlik-DürrExpanding EVAR indications with a next generation AAA endograft conforming to 90 degree neck angulations
Tomislav StojanovicTreating challenging peripheral lesions: the importance of flexibility and accuracy of placement. Case experiences with the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis

* Competing for the MAC Award

08.30-10.15

PAD 5: The future of interventional PAD treatment – drug-eluting technologies, atherectomy, and novel bypass techniques | Lecture Hall B

Chair: Achim Neufang, Mihai Ionac
Pierre Sarradon*Totally percutaneous fem-pop bypass – the bypass technique of the future?
Dainis KrievinsPQ Bypass or DETOUR procedure – no need for conventional femoral bypass surgery?
Nabil ChakféCharacterization of aortoiliac calcifications
Franco GregoCurrent treatment of severe aortoiliac obstructive disease in low-risk and young patients
Thomas ZellerAre nitinol-woven stents really superior to other self-expanding stents for distal femoro-popliteal lesions?
Iris BaumgartnerInverse probability weighted comparison of interwoven nitinol with drug-eluting stents for femoropopliteal artery disease
Nabil ChakféAnalysis of explanted peripheral stents – how do they look like and how did they change?
Gunnar TepeKeynote lecture: Future perspectives of drug-eluting technologies, atherectomy, and intravascular lithotrypsy
Thomas ZellerPaclitaxel and mortality – the dose argument is critical
Christian BehrendtKeynote lecture: Do “real-world” data confirm differences in mortality after PAD treatment with paclitaxel-coated devices?

13.30-14.30

PAD 6: Update on platelet inhibition and anticoagulation in PAD | Lecture Hall C

Chair: Sebastian Debus, Nicholas Leeper
Christine Espinola-KleinAnti-thrombotic therapy after peripheral revascularization
Thomas StadlbauerThe combination of antiplatelets and anticoagulants improves long-term outcomes in PAD patients
Michael NäbauerAtrial fibrillation, recent coronary events, and PAD – how to combine NOAKs, vitamin K antagonists, and antiplatelets
Achim NeufangAre there any patients, who still need anticoagulation after peripheral bypass surgery?

* Competing for the MAC Award

10.30-12.10

AOR 6: Translational research on aortic aneurysms | Lecture Hall C

Chair: Nabil Chakfé, Lars Maegdefessel
Rebecka HultgrenThe influence of sex or gender on rupture risk in AAA patients
Matti AdamNecroptosis in AAA disease
Uwe RaazRole of vascular stiffness in AAA disease
Christine BrostjanThe role and therapeutic relevance of neutrophil extracellular traps in the progression of AAA
Wolf EilenbergMetAAA-study: Metformin – inhibition of progression in abdominal aortic aneurysm
Sonja Bleichert*Nuclear vs. mitochondrial pathways of extracellular trap formation in abdominal aortic aneurysms
Albert BuschLocal or systemic delivery of Lenvatinib effectively inhibits experimental aneurysm progression
Natzi SakalihasanKeynote Lecture: PET-CT – an important tool to detect small AAAs
with an increased rupture risk and to predict complications after EVAR

13.00-13.25

How to heal medical culture – reducing the risks of „burn-out" | Lecture Hall B

Tait Shanafelt, Stanford University interviewed by Pavlos Tsantilas

14.30-15.30

Special Session 2: the future of Vascular Surgery 2 – digitalization, robots, and artificial intelligence | Lecture Hall C

Chair: Markus Kleemann, Jonas Peter Eiberg
Bijan ModaraiArtificial intelligence and its transformative role in image analysis for aortic intervention
Rachel CloughArtificial intelligence, big-data, and cloud computing in vascular surgery
Alan LumsdenRobots in the vascular room and remote case support
Mark KaschwichRobotic-assisted ultrasound for endovascular peripheral procedures
Mark KaschwichRobotic-assisted ultrasound for AAA screening
Bernhard DorweilerCurrent applications of 3D-printing in vascular surgery

16.00-17.00

Special Session 3: vascular infections | Lecture Hall C

Chair: Matthias Trenner, Henrik Sillesen
Christoph NeumayerInfected grafts after open AAA repair
Clark ZeebregtsDiagnostic imaging in vascular graft infection – a systematic review and meta-analysis
Bartosz RylskiXenopericardium for the treatment of native aortic and graft infections from the root to the bifurcation – long term results
Albert Busch, Gabor BiroInfected aortic endografts – replacement by specifically designed xenopericardial grafts – technique and outcomes
Anders WanhainenSystematic review of the management of mycotic aortic aneurysms
Bernhard DorweilerBiosynthetic grafts for native and prosthetic vascular graft infection